Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP3652 in CP/CPPS
NCT01391338Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 2, randomised, double-blind trial of asp3652 in chronic pelvic pain syndrome (CPPS) (6 arms), sponsored by Astellas Pharma. Primary endpoint: National Institutes of Health-Chronic Prostatitis Symptom Index Total Score at 12 weeks. Started Jun 2011; status: completed.
02
Drugs
asp3652
03
Conditions
chronic pelvic pain syndrome (CPPS)
Beyond the preview
Go deeper on NCT01391338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01391338.